NASDAQ:ANZU - Nasdaq - US03737A1016 - Common Stock - Currency: USD
Envoy Medical shares plummeted 30% in their market debut following the hearing device maker's merger with SPAC Anzu I. Read more here.
SPAC Anzu and Envoy Medical shareholders have approved their merger deal, with shares of the combined company expected to begin trading on Oct. 2.
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.
On Friday, shares of Anzu Special Acquisition Corp I (NASDAQ: ANZU) experienced volatile short activity. After the activity, the stock price went down 0% to $9.80. The overall sentiment for ANZU has been Bullish.